Theralizumab (TGN1412) 是一种超级激动剂抗CD28单克隆抗体,可直接刺激 T 细胞。Theralizumab 可用于类风湿性关节炎的研究。
生物活性 | Theralizumab (TGN1412) is a superagonist anti-CD28monoclonal antibody that directly stimulates T cells. Theralizumab can be used for the research of rheumatoid arthritis[1][2]. |
性状 | |
CAS 号 | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |